Aurinia Pharmaceuticals Inc. (AUPH) Stock buybacks 2022–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$98.2MFY2025 · since FY2022: $0 → $98.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $98.2M | +143.9% |
| FY2024 | $40.2M | — |
| FY2023 | $0 | — |
| FY2022 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Net marginAUPH Gross profitAUPH Gross marginAUPH Operating incomeAUPH Operating marginAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →